<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zabmedvestnik</journal-id><journal-title-group><journal-title xml:lang="ru">Забайкальский медицинский вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Transbaikalian Medical Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">1998-6173</issn><publisher><publisher-name>Читинская государственная медицинская академия</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52485/19986173_2023_1_149</article-id><article-id custom-type="elpub" pub-id-type="custom">zabmedvestnik-134</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEWS</subject></subj-group></article-categories><title-group><article-title>Постковидный синдром у онкологических пациентов</article-title><trans-title-group xml:lang="en"><trans-title>Post-COVID syndrome in cancer patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каюкова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kayukova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000; ул. Горького, 39а; Чита</p></bio><bio xml:lang="en"><p>672000; 39A Gorky str.; Chita</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Болотов</surname><given-names>Э. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Bolotov</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000; ул. Горького, 39а; Чита</p></bio><bio xml:lang="en"><p>672000; 39A Gorky str.; Chita</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Читинская государственная медицинская академия» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chita State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>04</day><month>08</month><year>2024</year></pub-date><volume>0</volume><issue>1</issue><fpage>149</fpage><lpage>155</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Каюкова Е.В., Болотов Э.С., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Каюкова Е.В., Болотов Э.С.</copyright-holder><copyright-holder xml:lang="en">Kayukova E.V., Bolotov E.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.zabmedvestnik.ru/jour/article/view/134">https://www.zabmedvestnik.ru/jour/article/view/134</self-uri><abstract><p>   Новая коронавирусная инфекция связана с возникновением после перенесенного заболевания стойких симптомов, влияющих на повседневную жизнь, известных как постковидный синдром (ПКС). Особое место синдром занимает у онкологических пациентов, снижая качество жизни, обуславливая необходимость дифференциальной диагностики с прогрессированием или рецидивированием злокачественного заболевания у них, необходимостью отмены специализированного лечения из-за тяжести клинических проявлений. В статье приводится обзор литературы по теме ПКС, клинический случай ПКС у онкологического пациента. Учитывая выраженность постковидных расстройств у пациента с онкологическим заболеванием, неизученность данного явления, постановка диагноза сопровождалась определёнными трудностями.</p></abstract><trans-abstract xml:lang="en"><p>   Novel coronavirus infection is associated with the onset of persistent symptoms after illness that affect daily life, known as the post-COVID syndrome (PCS). The syndrome occupies a special category in oncological patients, reducing the quality of life, necessitating differential diagnosis with the progression or recurrence of a malignant disease in them. The article describes the literature review of PCS, a clinical case of PCS in an oncological patient, which arose during the dispensary observation of an oncologist. Given the severity of post-COVID disorders in a patient with cancer, the lack of knowledge of this phenomenon, the diagnosis was accompanied by certain difficulties.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>СOVID-19</kwd><kwd>постковидный синдром</kwd><kwd>онкология</kwd><kwd>рак</kwd></kwd-group><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>post-covid syndrome</kwd><kwd>oncology</kwd><kwd>cancer</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Описание клинического случая не имело финансовой поддержки</funding-statement><funding-statement xml:lang="en">Description of the clinical case is not had financial support</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lièvre A., Turpin A., Ray-Coquard I., et al., GCO-002 CACOVID-19 collaborators/investigators. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study. Eur J Cancer. 2020. 141. DOI: 10.1016/j.ejca.2020.09.035.</mixed-citation><mixed-citation xml:lang="en">Lièvre A., Turpin A., Ray-Coquard I., et al.; GCO-002 CACOVID-19 collaborators/investigators. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study. Eur J Cancer. 2020. 141. DOI: 10.1016/j.ejca.2020.09.035.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine [Internet]. 2021. 38. Available from: https://pubmed.ncbi.nlm.nih.gov/34308300</mixed-citation><mixed-citation xml:lang="en">Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine [Internet]. 2021. 38. Available from: https://pubmed.ncbi.nlm.nih.gov/34308300</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Salamanna F., Veronesi F., Martini L., Landini M.P., Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne) [Internet]. 2021. 45. DOI: 10.3389/fmed.2021.653516. Available from: https://pubmed.ncbi.nlm.nih.gov/34017846/</mixed-citation><mixed-citation xml:lang="en">Salamanna F., Veronesi F., Martini L., Landini M.P., Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne) [Internet]. 2021. 45. DOI: 10.3389/fmed.2021.653516. Available from: https://pubmed.ncbi.nlm.nih.gov/34017846/</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Хавинсон В.Х., Кузник Б.И., Рукавишникова С.А. и др. Влияние Тималина на показатели клеточного, гуморального иммунитета и качество жизни у пациентов пожилого возраста с COVID-19. Врач. 2021. 32. DOI: 10.29296/25877305-2021-06-09</mixed-citation><mixed-citation xml:lang="en">Khavinson V.K., Kuznik B.I., Volchkov V.A., et al. Effect of thymalin on adaptive immunity in complex therapy for patients with COVID-19. Clinical Medicine (Russian Journal). 2020. 988. DOI: 10.30629/0023-2149-2020-98-8-593-599.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Reese J., Blau H., Bergquist T., et al., and the RECOVER Consortium. Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER Programs. medRxiv. 2022. 225. DOI: 10.1101/2022.05.24.22275398.</mixed-citation><mixed-citation xml:lang="en">Reese J., Blau H., Bergquist T., et al., and the RECOVER Consortium. Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER Programs. medRxiv. 2022. 225. DOI: 10.1101/2022.05.24.22275398.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Maltezou H.C., Pavli A., Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel). 2021. 125. DOI: 10.3390/vaccines9050497.</mixed-citation><mixed-citation xml:lang="en">Maltezou H.C., Pavli A., Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel). 2021. 125. DOI: 10.3390/vaccines9050497.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Silva Andrade B., Siqueira S., de Assis Soares W.R., et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 134. DOI: 10.3390/v13040700</mixed-citation><mixed-citation xml:lang="en">Silva Andrade B., Siqueira S., de Assis Soares W. R., et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 134. DOI: 10.3390/v13040700</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wells A.U., Devaraj A., Desai S.R. Interstitial Lung Disease after COVID-19 Infection: A Catalog of Uncertainties. Radiology. 2021. 294. DOI: 10.1148/radiol.2021204482.</mixed-citation><mixed-citation xml:lang="en">Wells A.U., Devaraj A., Desai S.R. Interstitial Lung Disease after COVID-19 Infection: A Catalog of Uncertainties. Radiology. 2021. 294. DOI: 10.1148/radiol.2021204482.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Graham E.L., Clark J.R., Orban Z.S., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021. 85. DOI: 10.1002/acn3.51350.</mixed-citation><mixed-citation xml:lang="en">Graham E.L., Clark J.R., Orban Z.S., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021. 85. DOI: 10.1002/acn3.51350.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Abbasi J. Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants. JAMA. 2021. 255. DOI: 10.1001/jama.2021.7212.</mixed-citation><mixed-citation xml:lang="en">Abbasi J. Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants. JAMA. 2021. 255. DOI: 10.1001/jama.2021.7212.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Weng J., Li Y., Li J., et al. Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol Hepatol. 2021. 65. DOI: 10.1016/S2468-1253(21)00076-5.</mixed-citation><mixed-citation xml:lang="en">Weng J., Li Y., Li J., et al. Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol Hepatol. 2021. 65. DOI: 10.1016/S2468-1253(21)00076-5.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Чистякова М.В., Зайцев Д.Н., Говорин А.В., Медведева Н.А., Курохтина А.А. “Постковидный” синдром: морфо-функциональные изменения и нарушения ритма сердца. Российский кардиологический журнал. 2021. 267. DOI: 10.15829/1560-4071-2021-4485</mixed-citation><mixed-citation xml:lang="en">Chistyakova M.V., Zaitsev D.N., Govorin, A.V., Medvedeva N.A., Kurokhtina A.A. Post-COVID-19 syndrome: morpho-functional abnormalities of the heart and arrhythmias. Russian Journal of Cardiology. 2021. 267. DOI: 10.15829/1560-4071-2021-4485. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021. 82. DOI: 10.1016/S2215-0366(20)30462-4</mixed-citation><mixed-citation xml:lang="en">Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021. 82. DOI: 10.1016/S2215-0366(20)30462-4</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Diotallevi F., Mazzanti S., Properzi P., Olivieri S., Giacometti A., Offidani A. Is there a POST-COVID dermatological syndrome? The integrated dermato-infectious disease experience of a single centre. J Eur Acad Dermatol Venereol. 2022. 363. DOI: 10.1111/jdv.17803.</mixed-citation><mixed-citation xml:lang="en">Diotallevi F., Mazzanti S., Properzi P., Olivieri S., Giacometti A., Offidani A. Is there a POST-COVID dermatological syndrome? The integrated dermato-infectious disease experience of a single centre. J Eur Acad Dermatol Venereol. 2022. 363. DOI: 10.1111/jdv.17803.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">von Meijenfeldt F.A., Havervall S., Adelmeijer J., Lundström A., Magnusson M., Mackman N., Thalin C., Lisman T. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 2021. 93. DOI: 10.1182/bloodadvances.2020003968.</mixed-citation><mixed-citation xml:lang="en">von Meijenfeldt F.A., Havervall S., Adelmeijer J., Lundström A., Magnusson M., Mackman N., Thalin C., Lisman T. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 2021. 93. DOI: 10.1182/bloodadvances.2020003968.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Pal R., Joshi A., Bhadada S.K., Banerjee M., Vaikkakara S., Mukhopadhyay S. Endocrine Follow-up During Post-Acute COVID-19: Practical Recommendations Based on Available Clinical Evidence. Endocr Pract. 2022. 284. DOI: 10.1016/j.eprac.2022.02.003.</mixed-citation><mixed-citation xml:lang="en">Pal R., Joshi A., Bhadada S.K., Banerjee M., Vaikkakara S., Mukhopadhyay S. Endocrine Follow-up During Post-Acute COVID-19: Practical Recommendations Based on Available Clinical Evidence. Endocr Pract. 2022. 284. DOI: 10.1016/j.eprac.2022.02.003.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">COVID-19 rapid guideline: managing the long-term effects of COVID-19. Свободный доступ 28. 11. 2022: https://www.nice.org.uk/guidance/ng188</mixed-citation><mixed-citation xml:lang="en">COVID-19 rapid guideline: managing the long-term effects of COVID-19. Available from 28. 11. 2022: https://www.nice.org.uk/guidance/ng188</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kalia R., Kalia R., Musih J., Cubelo M., &amp; Popat J. Post-COVID-19 Syndrome: A Novel Diagnosis. Cureus. 148. DOI: 10.7759/cureus.28266</mixed-citation><mixed-citation xml:lang="en">Kalia R., Kalia R., Musih J., Cubelo M., &amp; Popat J. Post-COVID-19 Syndrome: A Novel Diagnosis. Cureus. 148. DOI: 10.7759/cureus.28266</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome : A systematic review and meta-analysis. EClinicalMedicine. 2021. 245. DOI: 10.1016/j.eclinm.2021.100899.</mixed-citation><mixed-citation xml:lang="en">Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021. 245. DOI: 10.1016/j.eclinm.2021.100899.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Pinato D.J., Tabernero J., Bower M., et al.; OnCovid study group. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 2021. 2212. DOI: 10.1016/S1470-2045(21)00573-8.</mixed-citation><mixed-citation xml:lang="en">Pinato D.J., Tabernero J., Bower M., et al.; OnCovid study group. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 2021. 2212. DOI: 10.1016/S1470-2045(21)00573-8.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
